RankingsPricing
  1. JP-listed companies
  2. Cytori Cell Research Institute,Inc.

Cytori Cell Research Institute,Inc.JP:3750

Market cap
¥7.5B
P/E ratio
129.9x
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2012		Mar 31,
2013		Mar 31,
2014		Mar 31,
2015		Mar 31,
2016		Mar 31,
2017		Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023		Mar 31,
2024
Cash and deposits-2784091,1278402,3259961,5331,0001,0708521,1231,038
Accounts receivable - trade-817435437552134--408211711358
Merchandise--------123161162116104
Other-32101865194191212111119041436228
Current assets-2,3923,3564,4593,8342,8013,1287,2566,4806,2703,0291,3881,428
Other-32101865194191212111119041436228
Allowance for doubtful accounts--5-8-34-36-38-6------
Current assets-2,3923,3564,4593,8342,8013,1287,2566,4806,2703,0291,3881,428
Buildings-211--314823,7773,5814,4124,231981
Other, net--111681161506131420224467
Land------2,068-3,8723,8727,4267,2523,170
Property, plant and equipment-1881581681162,21867,6627,46712,04111,7274,218
Other, net--111681161506131420224467
Property, plant and equipment-1881581681162,21867,6627,46712,04111,7274,218
Goodwill-5036-----785739693647-
Other-145040292247462494221
Other-145040292247462494221
Intangible assets-6350402922485980174368921
Intangible assets-6350402922485980174368921
Deferred tax assets--------49-79157-
Other-29312721732262011373115130150
Investments and other assets-1730253313226220482387194287150
Deferred tax assets--------49-79157-
Other-29312721732262011373115130150
Allowance for doubtful accounts--350-347-355-573-581-------
Investments and other assets-1730253313226220482387194287150
Non-current assets-26851026272412,2452299,0038,65412,97812,7034,389
Assets-2,6873,8794,7213,9062,8415,3747,48515,48314,92416,00714,0925,816
Short-term borrowings---282218-2,20028027-16450070
Current portion of long-term borrowings-------11052152155340155
Current portion of long-term borrowings-------11052152155340155
Short-term borrowings---282218-2,20028027-16450070
Other-412414324064656495265214278272411
Current liabilities-8848321,5076741202,2568868137359951,174536
Long-term borrowings-------2,8908,2198,0138,5517,6062,347
Investments in silent partnerships--------9869721,0351,0790
Provision for retirement benefits-14-----------
Deferred tax liabilities--------1,3151,4011,5171,436125
Non-current liabilities-14172165432,99910,83710,64111,29510,2612,485
Other--021654310931825419214012
Non-current liabilities-14172165432,99910,83710,64111,29510,2612,485
Liabilities-8988481,5286801252,2983,88411,65011,37612,29011,4353,021
Share capital-3,6694,1604,1604,160100100100100100100100100
Capital surplus-1,2661,7571,7571,7572,9442,9442,3802,4082,6792,9392,9392,939
Capital surplus-1,2661,7571,7571,7572,9442,9442,3802,4082,6792,9392,9392,939
Retained earnings--27728148182-2821671,2571,442543463-597-459
Retained earnings--27728148182-2821671,2571,442543463-597-459
Treasury shares--2,868-2,871-2,871-2,872-45-136-137-137-1-1-1-1
Shareholders' equity-1,7893,0743,1933,2262,7173,0753,6013,8133,3213,5012,4412,579
Share acquisition rights---------224212212212
Valuation difference on available-for-sale securities---43------00000
Valuation and translation adjustments---43------00000
Net assets1,2561,7893,0313,1933,2262,7173,0753,6013,8333,5483,7162,6572,796
Share acquisition rights---------224212212212
Non-controlling interests--------203445
Net assets1,2561,7893,0313,1933,2262,7173,0753,6013,8333,5483,7162,6572,796
Liabilities and net assets-2,6873,8794,7213,9062,8415,3747,48515,48314,92416,00714,0925,816